Farber Disease Natural History Study

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

November 22, 2017

Primary Completion Date

October 12, 2019

Study Completion Date

December 9, 2019

Conditions
Farber DiseaseFarber's DiseaseFarber LipogranulomatosisAcid Ceramidase DeficiencyCeramidase DeficiencyN-Laurylsphingosine Deacylase DeficiencyASAH1 Mutation
Trial Locations (15)

5000

Hospital de Niños de la Santisima Trinidad, Córdoba

20010

Children's National Health System, Washington D.C.

35392

Universitätsklinikum Giessen, Zentrum für Kinderheilkunde und Jugendmedizin, Giessen

94609

UCSF Benioff Children's Hospital Oakland, Oakland

H4A 3J1

Montreal Children's Hospital, Montreal

Unknown

Cairo University, Cairo

Lok Nayak Hospital & Maulana Azad Medical College, Dehli

Sir Ganga Ram Hospital, Delhi

IRCCS Istituto Giannina Gaslini, Genoa

University of Milan, Milan

Astrid Lindgrens barnsjukhus, Karolinska University Hospital Solna, Stockholm

Cukurova University School of Medicine, Adana

Hacettepe University Medical Faculty Hospital, Ankara

Istanbul University Istanbul School of Medicine, Istanbul

Dokuz Eylul University School of Medicine, Izmir

All Listed Sponsors
lead

Sumitomo Pharma Switzerland GmbH

INDUSTRY

NCT03233841 - Farber Disease Natural History Study | Biotech Hunter | Biotech Hunter